Use of cross-linked hydrogel materials as image contrast agents in proton nuclear magnetic resonance tomography and tissue phantom kits containing such materials
CA 1279819 C · Owner: Novartis Pharmaceuticals Canada Inc./Novartis Pharma Canada Inc. · Inventors: Beall, Paula T.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Cross-linked hydrogel materials in the swollen state exhibit a range of nuclear magnetic resonance spin density values, spin-lattice or longitudinal relaxation (T1) values, and spin-spin or transverse relaxation (T2) values embracing that of the spectrum of values associated with animal and human tissues, thereby rendering such materials useful in nuclear magnetic resonance tomography equipment contrast determinations in physiological imaging and as to, those cross-linked hydrogel materials having T1 and T2 values substantially shorter than the surrounding tissue such materials are useful as image contrast agents for, example, in the gastro-intestinal tract.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 5, 1991. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 5, 2008.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.